| mAbs
| [0004]
[0004]
|
| Nature Biotechnology
| [0004]
[0004]
|
| MAbs
| [0004]
[0005]
|
| Nature
| [0004]
|
| Nature Biotechnology
| [0005]
|
| mAbs
| [0005]
|
| Protein Engineering
| [0005]
|
| J Biol Chem
| [0005]
|
| J Biol Chem
| [0005]
|
| J Immunol Methods
| [0006]
|
| Immunol Lett
| [0006]
|
| Nature Reviews Immunology
| [0006]
|
| Immunity
| [0006]
|
| J Immunol
| [0006]
|
| Nature Reviews Immunology
| [0006]
|
| Protein Engineering
| [0024]
|
| mAbs
| [0024]
|
| Protein Eng Des Sel
| [0024]
|
| Protein Engineering
| [0030]
[0111]
|
| J. Mol. Biol.
| [0030]
[0111]
|
| Nature Biotech.
| [0031]
[0111]
|
| J. Biol. Chem.
| [0032]
[0112]
|
| Proc Natl Acad Sci USA
| [0057]
|
| Journal of the American Chemical Society
| [0057]
|
| ChemBioChem
| [0057]
|
| PICAS United States of America
| [0057]
|
| Chem.
| [0057]
|
| PNAS USA
| [0058]
|
| Trends Genet.
| [0058]
|
| Proc Natl Acad Sci USA
| [0058]
|
| Science
| [0058]
|
| Immunological Reviews
| [0065]
|
| Immunol Lett
| [0066]
|
| SEQUENCES OF PROTEINS OF IMMUNOLOGICAL INTEREST
| [0083]
|
| J. Mol. Biol.
| [0083]
|
| SEQUENCES OF IMMUNOLOGICAL INTEREST
| [0089]
|
| Nature
| [0099]
|
| Science
| [0099]
[0099]
|
| Biotechnol. Prog.
| [0099]
|
| Humanization of Monoclonal Antibodies, Molecular Biology of B Cells
| [0099]
|
| Nature
| [0099]
|
| Nature
| [0099]
|
| Proc Natl Acad Sci, USA
| [0099]
|
| J. Immunol.
| [0099]
|
| Proc Natl Acad Sci USA
| [0099]
|
| Cancer Res.
| [0099]
|
| Proc. Natl. Acad. Sci. USA
| [0099]
|
| Protein Eng
| [0099]
|
| Proc. Natl. Acad. Sci. USA
| [0099]
|
| J. Mol. Biol.
| [0099]
|
| J. Biol. Chem.
| [0099]
|
| J. Biol. Chem.
| [0099]
|
| Proc. Natl. Acad. Sci. USA
| [0099]
|
| Protein Engineering
| [0099]
|
| J. Immunol.
| [0099]
|
| J. Immunol.
| [0099]
|
| Immunol Today
| [0127]
|
| J. Immunol.
| [0127]
|
| PEDS.
| [0128]
|
| Nature Biotech.
| [0136]
|
| Proteins: Structure and Molecular Properties
| [0147]
|
| Nat Biotechnol
| [0150]
|
| Biotechnol Bioeng
| [0150]
|
| J Biol Chem
| [0150]
|
| J Biol Chem
| [0150]
|
| CRC Crit. Rev. Biochem.
| [0154]
|
| Arch. Biochem. Biophys.
| [0155]
|
| Anal. Biochem.
| [0155]
|
| Meth. Enzymol.
| [0155]
|
| J. Biol. Chem.
| [0155]
|
| PEG Catalog from Nektar Therapeutics
| [0156]
|
| Proc. Natl. Acad. Sci. USA
| [0163]
|
| Structure
| [0163]
|
| technical section on cross-linkers
| [0164]
|
| Bioconjugate Chem.
| [0166]
|
| Cancer J.
| [0166]
|
| Current Opin. Chem. Biol.
| [0166]
|
| J. Nat. Cancer Inst.
| [0171]
|
| Bioorganic & Med. Chem. Letters
| [0171]
|
| Bioconjugate Chem.
| [0171]
|
| Proc. Natl. Acad. Sci. USA
| [0171]
[0177]
|
| Cancer Res.
| [0171]
|
| Cancer Res.
| [0171]
|
| PNAS
| [0173]
|
| Cancer Research
| [0178]
|
| Agents and Chemother
| [0179]
|
| Agents Chemother
| [0179]
|
| Proceedings of the American Association for Cancer Research
| [0180]
|
| The Peptides
| [0184]
|
| J. Am. Chem. Soc.
| [0184]
|
| Anti-Cancer Drug Design
| [0184]
|
| Synthesis
| [0184]
|
| J. Chem. Soc. Perkin Trans.
| [0184]
|
| Nat Biotechnol
| [0184]
|
| Cancer Research
| [0185]
|
| Cancer Research
| [0185]
|
| Biochem. Biophys. Res. Commun.
| [0192]
|
| Monoclonal Antibodies in Immunoscintigraphy
| [0192]
|
| Pharm. Therapeutics
| [0202]
[0204]
|
| Biol. Chem.
| [0204]
|
| Cancer Res.
| [0205]
|
| In Immunoconjugates: Antibody Conjugates in Radioimagery and Therapy of Cancer
| [0205]
|
| Anticancer Res.
| [0206]
|
| Bioorg-Med-Chem.
| [0206]
|
| Bioorg-Med-Chem.
| [0206]
|
| Intl. J. Oncology
| [0223]
|
| J. Natl. Cancer Inst.
| [0223]
|
| J. Immunol. Methods
| [0224]
|
| Roche Molecular Biochemicals
| [0225]
|
| Current Protocols in Immunology
| [0226]
|
| Cancer Research
| [0227]
|
| Nature Medicine
| [0228]
|
| Remington's Pharmaceutical Sciences
| [0229]
[0230]
[0232]
|
| Sequences of Proteins of Immunological Interest
| [0262]
|
| Mol. Immunol.
| [0283]
|